is glp 1r retatrutide First phase 3 data, a Triumph of Science! Retatrutide—A Game Changer in Obesity

GLP-1 medications can affect your salivary glands, reducing the amount of saliva your mouth produces

The regulatory environment for compounded GLP-1 medications is actively evolving as of May 2026

Reduced Daytime Fatigue: Some patients report feeling a temporary wave of tiredness after their injection

Beyond weight loss, the mechanistic reasons these may help in T1D include: reduced glucagon output, reduced hepatic glucose output, improved satiety signalling, and slower gastric emptying (which can improve matching when handled carefully)

These effects depend on the type, route of administration, dose, and duration of action of each specific GLP-1 receptor agonist, as well as individual characteristics such as baseline body weight and degree of glucose tolerance

A significance level of 5% was used